165 related articles for article (PubMed ID: 29277780)
1. The Contribution of Matrix Metalloproteinase-1 Promoter Genotypes in Taiwan Lung Cancer Risk.
Shen TC; Chang WS; Tsai CW; Chao CY; Lin YT; Hsiao CL; Hsu CL; Chen WC; Hsia TC; Bau DT
Anticancer Res; 2018 Jan; 38(1):253-257. PubMed ID: 29277780
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinase-1 Genotype Contributes to the Risk of Non-solid Tumor in Childhood Leukemia.
Pei JS; Hsu PC; Chou AK; Tsai CW; Chang WS; Hsiao CL; Hsu YN; Cheng SP; Bau DT
Anticancer Res; 2016 Oct; 36(10):5127-5132. PubMed ID: 27798872
[TBL] [Abstract][Full Text] [Related]
3. The Association of
Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
[TBL] [Abstract][Full Text] [Related]
4. The Contribution of Matrix Metalloproteinase-1 Genotype to Oral Cancer Susceptibility in Taiwan.
Sun KT; Tsai CW; Chang WS; Shih LC; Chen LY; Tsai MH; Ji HX; Hsiao CL; Liu YC; Li CY; Bau DT
In Vivo; 2016; 30(4):439-44. PubMed ID: 27381606
[TBL] [Abstract][Full Text] [Related]
5. The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Prostate Cancer in Taiwanese Patients.
Liao CH; Wu HC; Hu PS; Hsu SW; Shen TC; Hsia TC; Chang WS; Tsai CW; Bau DT
Anticancer Res; 2018 Jul; 38(7):3907-3911. PubMed ID: 29970511
[TBL] [Abstract][Full Text] [Related]
6. The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan.
Lai YL; Gong CL; Fu CK; Yueh TC; Tsai CW; Chang WS; Hsiao CL; Yen ST; Li HT; Jeng LB; Wang SC; Bau DT
Cancer Genomics Proteomics; 2017; 14(2):119-125. PubMed ID: 28387651
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase-1 Genetic Polymorphism in Breast Cancer in Taiwanese.
Su CH; Lane HY; Hsiao CL; Liu LC; Ji HX; Li HT; Yen ST; Su CH; Hsia TC; Chang WS; Tsai CW; Bau DT
Anticancer Res; 2016 Jul; 36(7):3341-5. PubMed ID: 27354592
[TBL] [Abstract][Full Text] [Related]
8. Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk.
Liao CH; Tsai CW; Chang WS; Wang ZH; Gong CL; Wu HC; Wang BR; Hsu SW; Huang WC; Shen TC; Bau DT
In Vivo; 2021; 35(5):2535-2540. PubMed ID: 34410940
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer.
O-charoenrat P; Leksrisakul P; Sangruchi S
Int J Cancer; 2006 May; 118(10):2548-53. PubMed ID: 16353148
[TBL] [Abstract][Full Text] [Related]
10. No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China.
Jin X; Kuang G; Wei LZ; Li Y; Wang R; Guo W; Wang N; Fang SM; Wen DG; Chen ZF; Zhang JH
World J Gastroenterol; 2005 Apr; 11(16):2385-9. PubMed ID: 15832405
[TBL] [Abstract][Full Text] [Related]
11. [Association of MMP1 -1607(1G>2G)single nucleotide polymorphism with susceptibility to lung cancer in Northwestern Chinese population of Han nationality].
Zhang WQ; Lin H; Zhou YA; Wang YJ; Cheng QS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):313-5. PubMed ID: 16767672
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase (MMP)-1 and MMP-3 gene variations affect MMP-1 and -3 serum concentration and associates with breast cancer.
Balkhi S; Mashayekhi F; Salehzadeh A; Saedi HS
Mol Biol Rep; 2020 Dec; 47(12):9637-9644. PubMed ID: 33170424
[TBL] [Abstract][Full Text] [Related]
13. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer.
Liu L; Wu J; Wu C; Wang Y; Zhong R; Zhang X; Tan W; Nie S; Miao X; Lin D
Cancer; 2011 Nov; 117(22):5172-81. PubMed ID: 21523769
[TBL] [Abstract][Full Text] [Related]
14. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer.
Wenham RM; Calingaert B; Ali S; McClean K; Whitaker R; Bentley R; Lancaster JM; Schildkraut J; Marks J; Berchuck A
J Soc Gynecol Investig; 2003 Sep; 10(6):381-7. PubMed ID: 12969782
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-1 mitral expression and -1607 1G/2G gene promoter polymorphism in mitral chordae tendinae rupture.
Lin TH; Yang SF; Chiu CC; Su HM; Wang CL; Voon WC; Lai WT; Sheu SH
Transl Res; 2013 May; 161(5):406-13. PubMed ID: 23116893
[TBL] [Abstract][Full Text] [Related]
18. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
[TBL] [Abstract][Full Text] [Related]
19. The polymorphism MMP1 -1607 (1G>2G) is associated with a significantly increased risk of cancers from a meta-analysis.
Lu L; Sun Y; Li Y; Wan P
Tumour Biol; 2015 Mar; 36(3):1685-93. PubMed ID: 25391421
[TBL] [Abstract][Full Text] [Related]
20. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
